Jennifer Poff
Nurse Practitioner · Beckley, WVNPI 1013203058
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 172 payments — averaging $21.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$575
- Zynex Medical, Inc.$441
- Novo Nordisk$381
- E.r. Squibb & Sons, L.L.C.$288
- Abbott$268
- Dexcom, Inc.$213
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,641100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $575 |
| Zynex Medical, Inc. | 2 | $441 |
| Novo Nordisk | 22 | $381 |
| E.r. Squibb & Sons, L.L.C. | 10 | $288 |
| Abbott | 13 | $268 |
| Dexcom, Inc. | 13 | $213 |
| AstraZeneca(2 entities) | 12 | $181 |
| Amgen | 12 | $168 |
| Phathom Pharmaceuticals, Inc. | 2 | $140 |
| GSK | 7 | $123 |
| Mylan Specialty L.p. | 4 | $85 |
| Insulet Corporation | 4 | $83 |
| Lilly USA, LLC | 4 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $70 |
| Nestle Healthcare Nutrition Inc. | 3 | $68 |
| Pfizer | 3 | $59 |
| Averitas Pharma Inc. | 3 | $51 |
| Aimmune Therapeutics, Inc. | 2 | $44 |
| Exact Sciences | 3 | $43 |
| Verona Pharma, Inc. | 2 | $43 |
| Johnson & Johnson | 1 | $38 |
| Boehringer Ingelheim | 2 | $29 |
| Recor Medical Inc | 1 | $25 |
| Medtronic | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Novartis | 1 | $20 |
| Rhythm Pharmaceuticals, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,641 in reported general payments places this provider in the 90th percentile of 649 nurse practitioner providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 65 | $70,362 |
| EliquisApixaban | 45 | $63,405 |
| VascepaIcosapent Ethyl | 50 | $41,775 |
| OzempicSemaglutide | 40 | $39,465 |
| Tresiba Flextouch U-200Insulin Degludec | 30 | $36,199 |
| MounjaroTirzepatide | 28 | $32,970 |
| FarxigaDapagliflozin Propanediol | 22 | $32,909 |
| LinzessLinaclotide | 28 | $29,517 |
| JardianceEmpagliflozin | 25 | $25,168 |
| XareltoRivaroxaban | 15 | $23,529 |
| TradjentaLinagliptin | 14 | $21,297 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 28 | $17,745 |
| JanuviaSitagliptin Phosphate | 15 | $13,521 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $12,670 |
| MyrbetriqMirabegron | 12 | $8,181 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $123 | $70,36265 claims |
| PfizerEliquis | $59 | $63,40545 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $181 | $50,65550 claims |
| Boehringer IngelheimJardiance, Tradjenta | $29 | $46,46539 claims |
| Novo NordiskOzempic | $381 | $39,46540 claims |
| Lilly USA, LLCMounjaro | $74 | $32,97028 claims |
| AbbVieLinzess | $575 | $29,51728 claims |
| Johnson & JohnsonXarelto | $38 | $23,52915 claims |
| Astellas Pharma US IncMyrbetriq | $21 | $8,18112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 649 nurse practitioner providers in West Virginia.
Other nurse practitioner in Beckley
- Destiny HowardBeckley$35K
- Rachael RigginsBeckley$19K
- Robin BlumeBeckley$18K
- Kellie VaughtBeckley$17K
- Lisa WalkerBeckley$17K
- Adam MeadeBeckley$10K
- Jenine WardBeckley$7K
- Mohammed JaweedBeckley$3K
- Miranda PlumleyBeckley$3K
- Lisa RichmondBeckley$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.